UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004112
Receipt number R000004917
Scientific Title Clinical Follow-Up After Vascular Therapy in Patients with Critical Limb Ischemia
Date of disclosure of the study information 2010/08/28
Last modified on 2019/03/16 15:56:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Follow-Up After Vascular Therapy in Patients with Critical Limb Ischemia

Acronym

Clinical Follow-Up After Vascular Therapy in Patients with Critical Limb Ischemia

Scientific Title

Clinical Follow-Up After Vascular Therapy in Patients with Critical Limb Ischemia

Scientific Title:Acronym

Clinical Follow-Up After Vascular Therapy in Patients with Critical Limb Ischemia

Region

Japan


Condition

Condition

Peripheral Artery Disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Long-term follow-up study in CLI patients after vascular treatment

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Freedom from all-cause death

Key secondary outcomes

Major adverse cardiovascular event (death, myocardial infarction and stroke), target vessel revascularization, limb amputation


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Medical refractory patients against conventional therapy, whom were performed any kinds of vascular therapy (bypass graft surgery, catheter intervention, and vascular regenerative therapy).

Key exclusion criteria

1) no evidence of angiological stenosis confirmed by angiography, 2) history of vascular surgery (within 30 days), 3) presence of any malignant disease or history of its treatment within 5 years, 4) untreated proliferative diabetic retinopathy, 5) smoker unable to quit smoking, 6) drug addiction of any kind (including alcohol), 7) evidence of active viral infection, 8) infectious osteomyelitis, and 9) complication of any serious disease affecting the patient's general condition

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Gen
Middle name
Last name Takagi

Organization

Nippon Medical School

Division name

Department of Cardiovascular Medicine

Zip code

113 8603

Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo

TEL

03-3822-2131

Email

gen52@nms.ac.jp


Public contact

Name of contact person

1st name Gen
Middle name
Last name Takagi

Organization

Nippon Medical School

Division name

Department of Cardiovascular Medicine

Zip code

113 8603

Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo

TEL

03-3822-2131

Homepage URL


Email

gen52@nms.ac.jp


Sponsor or person

Institute

Department of Cardiovascular Medicine, Nippon Medical School

Institute

Department

Personal name



Funding Source

Organization

JSPS-Kakenhi

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB-Nippon Medical School

Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo

Tel

03-3822-2131

Email

clinicaltrial@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本医科大学付属病院(Nippon Medical School, University Hospital)


Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2010 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Baseline clinical characteristics and procedural data were collected from hospital charts or databases. Clinical follow-up data were obtained from either a review of the hospital records or telephone contacts with the patients or their referring physicians.


Management information

Registered date

2010 Year 08 Month 27 Day

Last modified on

2019 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004917


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name